Our findings from liver tissue indicate that the HSD leads to metabolic dysfunction in the liver even in the CDr rats, that do not exhibit conventional signs or markers of diabetes after being subjected to a HSD. This evidence concerns the gene CHST3 and diabetes mellitus.